Hanmi Pharmaceutical Co

Hanmi Group (hereinafter referred to as Hanmi Group) was founded in 1973 by Mr. Lin Shengji and is headquartered in Seoul, South Korea. It adheres to the business philosophy of people-oriented and value creation, is committed to the research and development of prescription drugs, has more than 280 kinds of patented technologies, and is in a leading position in many fields such as antibiotics, cardiovascular, digestion, antitumor, and pediatrics. Provide more than 200 kinds of drugs for global clinical treatment, sell patents and transfer technology to internationally renowned drug manufacturers such as Roche, Novartis, and become a world-renowned pharmaceutical expert with its world-leading science and technology, advanced equipment, and drugs with significant efficacy. It also has subsidiaries such as Fine Chemicals, Kixing Research Institute, Pyeongtaek Antibiotic Factory, Medicare, etc., laying a solid foundation for its R&D, production and sales, and has developed into an international company through foreign subsidiaries in China, Japan, and the United Kingdom. Of professional pharmaceutical companies.